A review of nutritional problems and the cystic fibrosis lung transplant patient
A. Dosanjh,
A. Dosanjh
Scripps Research Institute, La Jolla, California, and Stanford University, Stanford, California, USA
Search for more papers by this authorA. Dosanjh,
A. Dosanjh
Scripps Research Institute, La Jolla, California, and Stanford University, Stanford, California, USA
Search for more papers by this authorA. Dosanjh MD, FCCP, c/o A.
10550 N. Torrey Pines Rd,
MEM131B, La Jolla,
CA 92037, USA
Abstract
Abstract: Lung transplantation is an option for some cystic fibrosis (CF) patients. CF is associated with a variety of non-pulmonary problems, which should be managed before and after tansplantation. This commentary discusses some of the nutritional issues affecting CF patients. Theses issues include: the need for nutritional supplements; gastrostomy tube placement; osteoporosis and disabetes.
References
- 1 Lynch JP, Martinez F. Lung transplantation: Who's a candidate? (Part 2). J Respir Dis 1996: 17: 393–412.
- 2 Bell SC, Bowerman AR, Davies CA, Campbell IA, Shale DJ, Elborn JS. Nutrition in adults with cystic fibrosis. Clin Nutr 1998: 17: 211–215.
- 3 Chaun H. Colonic disorders in adult cystic fibrosis. Can J Gastroenterol 2001: 15: 586–590.
- 4 Ott SM, Aitken ML. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998: 19: 555–567.
- 5 Nomori H, Kobayashi R. Postoperative pulmonary complications in patients undergoing thoracic surgery with special reference to preoperative respiratory muscle strength and nutrition. J Jpn Assoc Thorac Surg 1994: 42: 1272–1275.
- 6 Sharples L, Hathaway T, Dennis C, et al. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993: 12: 669–674.
- 7 Shapiro BJ, Veeraraghavan S, Barbers RG. Lung transplantation for cystic fibrosis: An update and practical considerations for referring candidates. Curr Opin Pulm Med 1999: 5: 365–370.
- 8 Forli L, Pedersen JI, Bjortuft O, Vatn M, Boe J. Dietary support to underweight patients with end-stage pulmonary disease assessed for lung transplantation. Respiration 2001: 68: 51–57.
- 9 Pichard C, Kyle UG, Jolliet P, et al. Treatment of cachexia with recombinant growth hormone in a patient before lung transplantation: A case report. Crit Care Med 1999: 27: 1639–1642.
- 10 Forli L, Bjortuft O, Vatn M, Kofstad J, Boe J. A study of intensified dietary support in underweight candidates for lung transplantation. Ann Nutr Metab 2001: 45: 159–168.
- 11 Starnes VA, Lewiston N, Theodore J, et al. Cystic fibrosis. Target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg 1992: 103: 1008–1014.
- 12 Ramsey BW, Farrell PM, Pencharz P, et al. Nutritional assessment and management in cystic fibrosis: A consensus report. Am J Clin Nutr 1992: 55: 108–116.
- 13 Madill J, Maurer JR, De Hoyos A. A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation 1993: 56: 347–350.
- 14
Beck CE,
Lin A,
Robbins RC,
Dosanjh A.
Improvement in the nutritional and pulmonary profiles of cystic fibrosis patients undergoing bilateral sequential lung and heart–lung transplantation.
Nutr Clin Practice
1997: 12: 216–221.
10.1177/088453369701200504 Google Scholar
- 15 Schweibel C, Pin I, Barnoud D, et al. Prevalence and consequences of nutritional depletion in lung transplant candidates. Eur Respir J 2000: 16: 1050–1055.
- 16 Plochl W, Pezawaas L, Artemiou O, Grimm M, Klepetko W, Heismayr M. Nutritional status, ICU duration and ICU mortality in lung transplant recipients. Intensive Care Med 1996: 22: 1179–1185.
- 17 Madill J, Gutierrez C, Grossman J, et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of a 90 day mortality following transplantation. J Heart Lung Transplant 2001: 20: 288–296.
- 18 Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001: 153: 345–352.
- 19 Donovan DS, Papadopoulas A, Staron RB, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 1998: 157: 1892–1899.
- 20 Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000: 162 (3 Part 1): 941–946.
- 21 Haworth CS, Selby PL, Adams JE, Mawer EB, Horrocks AW, Webb AK. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001: 56: 314–316.
- 22 Parasa RB, Maffulli N. Musculoskeletal involvement in cystic fibrosis. Bull Hosp Jt Dis 1999: 58: 37–44.
- 23 Schoch OD, Speich R, Schmid C, et al. Osteonecrosis after lung transplantation: Cystic fibrosis as a potential risk factor. Transplantation 2000: 69: 1629–1632.
- 24 Haworth C, Webb K, Egan J, et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000: 118: 434–439.
- 25 Haworth CS, Selby PL, Webb AK, Adams JE. Osteoporosis in adults with cystic fibrosis. J R Soc Med 1998: 91 (Suppl. 34): 14–18.
- 26 Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: A selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999: 54: 40–43.
- 27 Deieroi MH, Haug M. Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy. Clin Transpl 2000: 14: 439–448.
- 28 Hoang K, Alpert S, Chen I, et al. Diabetes and dyslipidemia: New model for cardiac graft vascular disease in Lewis inbred rates (Abstract). J Heart Lung Transplant 1996: 15: S97.
- 29 Livi U, Caforio Al, Grassi G, et al. Mid-term results of heart transplantation in diabetic patients. J Cardiovasc Surg 1994: 35: 115–118.
- 30 Munoz E, Lonquist JL, Roadovancevic B, et al. Long-term results in diabetic patients undergoing heart transplantation in diabetic recipients. Surgery 1993: 114: 650–656.
Citing Literature
